RxDoctor Payments Data

Eric Spivack

Cardiovascular Disease · Aventura, FLNPI 1336296789

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 5 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 91.2% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2020 at $286 and has fallen 59.9% since, to $115 in 2022. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.

$439in general payments, 2019–2025

Across 5 payments — averaging $87.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$400
  • AbbVie$20
  • Novartis$19
$7,140,120in research payments, 2019–2025

Across 10 payments — averaging $714,012 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$6.1M
  • Astrazeneca UK Limited$953K
  • Currax Pharmaceuticals LLC$61K
  • AstraZeneca$18K

What the payments were for

  • Food & beverage$439100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)3$400
AbbVie1$20
Novartis1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$439 in reported general payments places this provider in the 15th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Other cardiovascular disease in Aventura

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →